Bacil Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bacil Pharma Ltd. on BSE

Search Inside the pdf :

Bacil Pharma Ltd.

27 Aug 2025

36.90

-1.60%

Company Update

Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Revised Outcome Of Board Meeting Held …

BSE India

Revised outcome of Board Meeting held on 25th August 2025. The earlier revised outcome uploaded has incorrect w.e.f date of appointment of statutory auditor. The correct w.e.f date is 25th August,2025

pdf

Bacil Pharma Ltd.

27 Aug 2025

36.90

-1.60%

Company Update

Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

BSE India

Approval for Appointment of M/s Sarang Shivajirao Chavan & Associates as the Statutory Auditor of the Company.

pdf

Bacil Pharma Ltd.

27 Aug 2025

36.90

-1.60%

Company Update

Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Revised Outcome Of Board Meeting Held …

BSE India

Revised outcome of Board Meeting on 25th August 2025

pdf

Bacil Pharma Ltd.

25 Aug 2025

36.90

-1.60%

Company Update

Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

BSE India

Announcement under Regulation 30 (LODR) - Appointment of Statutory Auditor M/s Sarang Shivajirao Chavan & Associates

pdf

Bacil Pharma Ltd.

25 Aug 2025

36.90

-1.60%

Board Meeting

Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Outcome of Board meeting for Appointment Statutory Auditor and Independent Director .

pdf

Bacil Pharma Ltd.

19 Aug 2025

36.90

-1.60%

Board Meeting

Bacil Pharma Ltd - 524516 - Board Meeting Intimation for We Wish To Inform That The …

BSE India

Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2025 ,inter alia, to consider and approve 1. Discussion on Appointment of M/s Sarang Shivajirao Chavan& Associate as a Statutory Auditor of the Company; 2. Discussion on Appointment of New Director. 3. Any other business with the permission of Chairperson.

pdf

Bacil Pharma Ltd.

14 Aug 2025

36.90

-1.60%

Company Update

Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors

BSE India

Intimation for Resignation of Statutory Auditor of the Company

pdf

Bacil Pharma Ltd.

14 Aug 2025

36.90

-1.60%

Company Update

Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper clipping for Unaudited Financial Results for the quarter ended 30th June, 2025

pdf

Bacil Pharma Ltd.

12 Aug 2025

36.90

-1.60%

Result

Bacil Pharma Ltd - 524516 - Results Financial Results For The Quarter Ended 30/06/2025

BSE India

Approval of unaudited financial results for the quarter ended 30th June 2025

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	1.00	0.09	0.01	1011.1%	9900.0%
Operating Profit Qtr	-0.11	-0.07	-0.04	-57.1%	-175.0%
Net Profit Qtr	0.67	0.02	-0.03	3250.0%	2333.3%
Earning Per Share Adjusted latest Qtr	1.14	0.03	-0.06	3700.0%	2000.0%